MPCI Wait for the downtrend to break, then buy
Use the right capital management and follow the rules of risk management.. it will protect your capital
11.331 EGP
191.46 M EGP
871.91 M EGP
4.89 M
About MEMPHIS PHARMACEUTICALS
Sector
CEO
Basem Mohamed Abdullah
Headquarters
Cairo
Website
Founded
1940
ISIN
EGS38351C010
FIGI
BBG000HGL3D1
Memphis Pharmaceutical & Chemical Industries engages in the manufacture of medicines and other pharmaceutical products for human and veterinary use. Its products include effervescent tablets, syrup, cream, injections, tablet and capsules, and suppository. The company was founded on July 20, 1940 and is headquartered in Cairo, Egypt.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MPCI is 57.610 EGP — it has increased by 1.02% in the past 24 hours. Watch MEMPHIS PHARMACEUTICALS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EGX exchange MEMPHIS PHARMACEUTICALS stocks are traded under the ticker MPCI.
MPCI stock has fallen by −1.66% compared to the previous week, the month change is a 11.56% rise, over the last year MEMPHIS PHARMACEUTICALS has showed a 192.56% increase.
MPCI reached its all-time high on Oct 15, 2024 with the price of 69.500 EGP, and its all-time low was 0.221 EGP and was reached on Jun 3, 2008. View more price dynamics on MPCI chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MPCI stock is 2.26% volatile and has beta coefficient of −0.14. Track MEMPHIS PHARMACEUTICALS stock price on the chart and check out the list of the most volatile stocks — is MEMPHIS PHARMACEUTICALS there?
Today MEMPHIS PHARMACEUTICALS has the market capitalization of 1.31 B, it has decreased by −2.74% over the last week.
Yes, you can track MEMPHIS PHARMACEUTICALS financials in yearly and quarterly reports right on TradingView.
MPCI net income for the last quarter is 25.09 M EGP, while the quarter before that showed 83.48 M EGP of net income which accounts for −69.94% change. Track more MEMPHIS PHARMACEUTICALS financial stats to get the full picture.
Yes, MPCI dividends are paid annually. The last dividend per share was 4.00 EGP. As of today, Dividend Yield (TTM)% is 1.16%. Tracking MEMPHIS PHARMACEUTICALS dividends might help you take more informed decisions.
MEMPHIS PHARMACEUTICALS dividend yield was 13.37% in 2024, and payout ratio reached 35.30%. The year before the numbers were 6.46% and 12.44% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEMPHIS PHARMACEUTICALS EBITDA is 220.24 M EGP, and current EBITDA margin is 25.37%. See more stats in MEMPHIS PHARMACEUTICALS financial statements.
Like other stocks, MPCI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEMPHIS PHARMACEUTICALS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEMPHIS PHARMACEUTICALS technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEMPHIS PHARMACEUTICALS stock shows the buy signal. See more of MEMPHIS PHARMACEUTICALS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.